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I. INTRODUCTION

The Supreme Court's review of Glossip v. Gross' drew the successful
efforts of the anti-death penalty camp-comprised of human rights
organizations and anti-death penalty lawyers-to lobby pharmaceutical
companies to cease supplying chemicals for use in lethal injection
protocol. Lethal injection is currently the primary vehicle through which
departments of correction execute prisoners, 2 and departments of
correction use various cocktails across the country. 3 Petitions for habeas
corpus rarely achieve relief for capitally charged clients. 4 As a result,
1. Glossip v. Gross, 135 S. Ct. 2726 (2015).
2.

See Methods of Execution, DEATH PENALTY INFORMATION CENTER, http://www.

deathpenaltyinfo.org/methods-execution (last visited July 25, 2015) (stating that 33 states, the
U.S. military, and the U.S. government all use lethal injection as their primary method of
execution).
3.

State-by-State

Lethal

Injection,

DEATH

PENALTY

INFORMATION

CENTER,

http://www.deathpenaltyinfo.org/state-lethal-injection (last visited Sept. 21, 2015) (detailing that
Georgia's lethal injection protocol uses a one drug protocol involving pentobarbital).
4. See, e.g., Glossip, 135 S. Ct. at 2746 (holding that plaintiffs did not show that the use
of midazolam in a lethal injection protocol would cause a substantial risk of harm). But see Jones
v. Chappell, 31 F. Supp. 3d 1050, 1051 (C.D. Cal. 2014) (finding that California's capital
punishment scheme was unconstitutional because of the unnecessary delays involved and the
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anti-death penalty advocates are turning to other means of seeking relief
for capitally charged prisoners with the ultimate goal of permanently
halting their executions. Recent tactics anti-death penalty advocates have
used to achieve these means have taken two distinct forms: (1) lobbying
pharmaceutical companies to cease the sale of drugs used in statesanctioned executions, and (2) using civil rights litigation under 42
U.S.C. § 1983 to argue that current execution protocol violates a
prisoner's constitutional rights.5 Pharmaceutical companies currently
6
hold a great deal of power in the potential end to the death penalty.
Civil rights litigation under 42 U.S.C. § 1983 ("§ 1983 litigation") has
generally not been a successful means of achieving relief for capitally
charged clients. 7 The Supreme Court has reviewed § 1983 litigation in
two cases out of Kentucky and Oklahoma federal courts. 8 In both cases,
the Supreme Court could not find sufficient evidence that the lethal
injection protocols petitioners challenged would violate a prisoner's
Eighth Amendment rights. 9
While § 1983 litigation generally has been unsuccessful in halting
state-sanctioned execution, human rights activists have been successful
overall in lobbying and eventually convincing pharmaceutical companies
to cease the production of certain drugs for use in lethal injection
protocols.' 0 As the use of midazolam in lethal injection protocols is now
arbitrariness with which it is implemented; this case was later reversed on Nov. 12, 2015).
5. See generally 42 U.S.C. § 1983 (2015) (mandating that where any individual subjects
another to the deprivation of rights or privileges afforded to them by the U.S. Constitution, this
individual will be subject to liability for such deprivation).
6. Cf Roche Statement, infra note 11 (showing that pharmaceutical companies are already
declining to supply midazolam for lethal injection in the wake of Glossip); Voltz, infra note 71
(detailing the ways in which pharmaceutical companies' decline to procure drugs for lethal
injection has substantially slowed the process of executions).
7. See, e.g., Glossip, 135 S. Ct. at 2731 (affirming a lower court decision to deny relief
under 42 U.S.C. § 1983 to clients facing the death penalty).
8. Id. at 2728 (examining a claim that Oklahoma's use of midazolam in lethal injection
procedures amounted to an Eighth Amendment violation); Baze v. Rees, 553 U.S. 35 (2008)
(assessing whether or not Kentucky's three drug protocol violated an individual's Eighth
Amendment rights to not be subjected to cruel and unusual punishment).
9. Glossip, 135 S. Ct. at 2741 (finding no Eighth Amendment violation because the
petitioner failed to provide adequate evidence to rebut the District Court's assertions that
midazolam can render a person unable to feel pain); Baze, 553 U.S. at 51 (declining to find
Kentucky's three drug protocol presented a substantial risk of future harm, and therefore violated
petitioner's Eighth Amendment rights).
10. Cf Glossip, 135 S. Ct. at 2733 (cataloging the reasons for which drug companies have
declined to continue to supply drugs for lethal injection, which include focusing on drug
company's European counterparts to demand that potentially lethal chemicals are not used for
lethal injection purposes). See also Raymond Bonner, Letterfrom Europe;Drug Company Caught
in Cross Hairs of Death Penalty Opponents, N.Y. TIMEs (Mar. 30, 2011), http://www.nytimes.
com/2011/03/3 1/world/europe/3liht-letter31.html?_r=0 (examining the efforts of anti-death
penalty activists in stopping European companies from supplying lethal injection drugs to the
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public knowledge after the media coverage surrounding Baze v. Rees,
pharmaceutical companies have begun to speak out against midazolam's
use in executions and to condemn capital punishment in general.'1
As pharmaceutical companies decline to supply drugs for the purpose
of state-sanctioned execution, this decline has forced states to turn toward
more unorthodox methods. 12 Should companies continue to bar the sale
of drugs for state-sanctioned execution, the Supreme Court could likely
decide under current Eighth Amendment jurisprudence of evolving
standards of decency that modem execution protocol violates Eighth
13
Amendment prohibitions on cruel and unusual punishment.
This Article will argue that § 1983 litigation will show a "substantial
risk of future harm," which the Court in Baze 14 outlines is necessary to
find a method of execution unconstitutional as lack of support from
pharmaceutical companies prompt more unorthodox methods of
execution. Part II will first review the history of death penalty litigation
and the ways in which lethal injection protocols have adapted as
pharmaceutical companies decline to procure certain drugs for lethal
injection cocktails. Second, it will explore the governing tests for
determining whether or not a method of execution is constitutional and
examine the Eighth Amendment jurisprudence under which a prisoner
may prove that a method of execution is not constitutional. Third, it will
examine the history of pharmaceutical companies' refusals to date to sell
certain drugs for use in lethal injection protocols and the ways in which
pharmaceutical companies have prompted changes to lethal injection
protocols. Fourth, it will examine the history of other business
involvement in civil rights litigation and the importance of business
involvement in civil rights victories.
Part III will first explore the effect that a lack of midazolam could
have on the efficiency and frequency of execution by lethal injection, and
United States, or supplying it with a stipulation that the drug cannot be used in state-sanctioned
executions).
11. See, e.g., Roche Statement: Statement on the Use of Midazolamfor the Death Penalty,
RocHE (Jan. 16, 2015), http://www.deathpenaltyinfo.org/documents/RocheStatement.pdf
[hereinafter Roche Statement] (showing that Roche openly condemns the use of midazolam's use

in lethal injection protocol and states that it will not knowingly allow midazolam to be used in
such procedures).
12.

See, e.g., Methods of Execution, supra note 2 (stating that in 2015, Oklahoma signed a

bill authorizing the use of nitrogen gas should lethal injection become an unavailable method of
execution).
13.

See, e.g., Roper v. Simmons, 543 U.S. 551, 560-61 (2005) (invoking Supreme Court

dicta which interprets that the Eighth Amendment must be interpreted under the "evolving
standards of decency that mark the progress of a maturing society") (citing Trop v. Dulles, 356
U.S. 86, 100-01 (1958)); Thompson v. Oklahoma, 487 U.S. 815, 822-23 (1988) (utilizing evolving

standards of human decency to find that execution of juveniles is unconstitutional).
14.

Baze, 553 U.S. at 49.
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what other methods could be used in place of that. Second, it will then
examine how this could affect the cruel and unusual punishment analysis
of lethal injection as a method of execution. Third, it will examine the
business considerations that explain the current decline in pharmaceutical
companies' willingness to procure lethal injection chemicals and will
compare and contrast the ways in which the decline in pharmaceutical
company support of the death penalty mirrors business involvement in
other civil rights litigation. Fourth, it will examine how the
pharmaceutical industry's general disdain for participation in lethal
injection cocktails affects court decisions and could affect future Eighth
Amendment analyses of lethal injection and capital punishment. This
Article will also examine how these changes in protocols have affected
the frequency with which lethal injection is carried out and the role this
has played in many states' decisions to cease the use of capital
punishment.
Part IV will recommend that anti-death penalty advocates view the
lobbying of pharmaceutical companies as a crucial step in overall
litigation strategy to end the death penalty. It will also recommend that
should anti-death penalty lobbyists-both lawyers and human rights
activists-wish to create an environment where under Eighth
Amendment jurisprudence, courts will find the standards for lethal
injection unacceptable, they should view the role of the pharmaceutical
industry as crucial to this end.
11. How PHARMACEUTICAL COMPANIES HAVE BEEN IMPORTANT IN
DEATH PENALTY LITIGATION TO DATE

When the Supreme Court heard Glossip in its Spring 2015 term,
petitioners charged the Court with deciding whether or not midazolam is
a constitutional means of execution. 15 In their assessment of whether or
not midazolam provides a constitutional method of execution, the Court
discussed the causes and effects of the decline in availability of lethal
injection drugs. 16 In the Court's majority opinion, Justice Alito addressed
the pharmaceutical lobby from the anti-death penalty camp, analyzing the
ways in which anti-death penalty lawyers and activists have sought to end
capital punishment entirely in the United States outside of the courts and
the traditional appeals process.' 7 Alito characterized pharmaceutical
lobby attempts as problematic because the decline in more traditional
lethal injection chemicals has slowed down the process and has prompted
15. Glossip, 135 S. Ct. at 2731.
16. See id at 2733 (listing the ways in which anti-death penalty activists have sought to
delay executions through the pharmaceutical lobby and civil suits).
17. Id.
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8

A. BriefHistory of the Death Penalty in American Jurisprudence
The Supreme Court has to date not found any method of execution
per se unconstitutional.' 9 The constitutionality of capital punishment in
general remained unchallenged in American jurisprudence until 1972,
when the Supreme Court reviewed the state of capital punishment in
Furman v. Georgia.2 ° In Furman, the Court held that the way in which
the state administered capital punishment was arbitrary and
discriminatory in nature as it mainly targeted minority and African
American populations, and the Court struck it down. 2 1 In 1976, the Court
took to revisit the question of whether or not capital punishment
inherently violated the Eighth Amendment in Gregg v. Georgia.2 2 The
Court found that under certain statutory schemes, and with very direct
guidelines regarding sentencing, states could put an2 3individual to death
without violating Eighth Amendment jurisprudence.
Since the reinstatement of the death penalty under Gregg in 1976, the
majority of states have begun to move toward lethal injection as a primary
method of execution. 24 Initially, all states used a three-drug protocol
comprised of sodium thiopental, pancorium bromide and potassium
chloride, which was ruled constitutional in Baze.25 However, in recent
years, states have moved toward other protocols because of complications
with supply. 26 Many states still retain alternative methods of execution,
18. See, e.g., id.; see also Voltz, infra note 71 (detailing the substantial delays in executions
caused by the lack of available lethal injection drugs).
19. See, e.g., Glossip, 135 S. Ct. at 2733 (declining to find Oklahoma's two drug protocol
violated Eighth Amendment jurisprudence); Baze, 553 U.S. at 51 (asserting that petitioners did

not adequately establish that Kentucky's three-drug protocol established the substantial risk of
future harm necessary to find the protocol violated the Eighth Amendment); In re Kemmler, 138
U.S. 436, 443 (1890) (per curiam) (holding that under the Eighth Amendment jurisprudence of

the nineteenth century, electrocution did not violate an individual's Eighth Amendment rights).
20.
21.

Furman v. Georgia, 408 U.S. 238, 239 (1972) (per curiam).
Id. at 239-40 (finding that capital punishment constituted cruel and unusual punishment

because of the discriminatory manner in which it was administered).
22.

Gregg v. Georgia, 428 U.S. 153, 158 (1976).

23. See id at 195 (mandating that where a legislature seeks to have a constitutional death
penalty statute, they must ensure that a sentencing authority is given the appropriate amount of
guidance and information to impose the sentence constitutionally).
24. See Methods of Execution, supra note 2 (showing that 33 states, the U.S. military, and

the U.S. government all use lethal injection as their primary method of execution).
25. See Baze v. Rees, 553 U.S. 35, 63 (2008) (mandating that a three-drug protocol of
sodium thiopental, pancuronium, and potassium chloride is constitutional and provides very little

margin for error).
26.

See Glossip v. Gross, 135 S. Ct. 2726, 2733-35 (2015) (evaluating when sodium

thiopental was no longer able to be procured, states began to move toward using pentobarbital,
and that when pentobarbital became unavailable many states began to substitute in midazolam).
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27
even where lethal injection may be their primary method of execution.
The majority of statutes outlining the protocol for lethal injection do
not specify the use of a particular type of chemical. Rather, these statutes
state that a substance of lethal quantity must be run through an
individual's veins until he or she is pronounced dead. 28 These loose
statutory requirements defer to the Department of Corrections and federal
choose which chemicals will be used in a
or state death row wardens2 to
9
execution.
state-sanctioned

B. Death Penalty Litigation Before the Use of Civil Rights Litigation
Pursuantto 42 U.S.C. § 1983
Post-conviction litigation and any attempts to attain relief for both
capitally charged prisoners and prisoners serving lesser sentences
traditionally take the form of petitions for a writ of habeas corpus. 30 in
exhausting all possible litigation options, a prisoner must first petition the
state for a writ of habeas corpus, and, if the petition for habeas corpus in
state court is unsuccessful, the prisoner can then petition for habeas
corpus in federal court.31 When a prisoner's remedies are entirely
exhausted, he or she can petition for clemency to a state governor, or to
if the crime prompting a capital charge was a federal
the president
32
crime.
Generally, these petitions have not been entirely successful at granting
relief.3 3 The lack of success these petitions produce has prompted the
27. See Methods of Execution, supra note 2 (noting that 8 states with lethal injection as
their primary method of execution have the option of electric chair, 5 states have the option of gas
chamber, 3 states have the option of hanging, and 3 have the option of firing squad).
28. See KY. REV. STAT. ANN. § 431.200 (West 2015) (stating that a person is executed
when a lethal dose of one substance or a combination of substances is run through their veins until
dead); 22 OKLA. STAT. ANN. tit. 22 § 1014 (West 2015); VA. CODE ANN. § 53.1-233 (West 2007).
29. See generally VA. CODE ANN. § 3.1-233 (showing the deferment to Departments of
Correction to decide).
30. See generally 28 U.S.C. § 2255 (2015) (detailing the process through which a prisoner
should appeal his conviction by petitioning for a writ of habeas corpus).
31. Compare TENN. CODE ANN. § 29-21-101 (detailing the grounds for which habeas
corpus can be granted under Tenn. law) and VA. CODE ANN. § 8.01-654 (West 2015) (clarifying
what is necessary for a grant of habeas corpus in Va.), with 28. U.S.C. § 2255 (2015) (mandating
how a prisoner can petition the federal government for a writ of habeas corpus).
32. See, e.g., U.S. CONST. art. II § 2, cl. 2 (stating that the president has the power to pardon
and grant reprieves for crimes against the United States); VA. CONST. art. V § 12 (decrying that
the Virginia governor has the power to grant clemency to a prisoner after all other appeals are
exhausted).
33. See, e.g., Strickland v. Washington, 466 U.S. 668, 700-01 (denying petitioner's request
for a writ of habeas corpus because petitioner failed to show that his counsel was so ineffective
that it prejudiced the outcome of his trial). But see Jones v. Chappell, 31 F. Supp. 3d 1050, 1069
(C.D. Cal. 2014) (vacating a death sentence and finding that because the system is arbitrary and
causes too much delay, California's capital punishment scheme must change to fix these delays
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34
attempt to challenge lethal injection through civil rights litigation.

C. The Use of 42 US.C. § 1983 in Death Penalty Litigation
A remedy is found in 42 U.S.C. § 1983 which provides to parties who
may have been deprived of privileges, constitutional rights, or immunities
by an official's abuse of his or her position. 35 In the context of the death
penalty, individuals can demand a remedy for any constitutional
violations a death sentence may implicate. 36 Plaintiffs usually request a
preliminary injunction to halt execution because a method of execution
would cause undue harm, violating their Eighth Amendment rights, and
because a lack of proper information regarding their execution protocol
violates their due process rights. 37 A lawsuit filed under 42 U.S.C. § 1983
must be filed in federal court.3 8
Glossip began as a lawsuit filed in federal district court in Oklahoma
pursuant to 42 U.S.C. § 1983. Prior to the Glossip decision, the Supreme
Court heard Baze v. Rees, 3 9 a challenge to the Kentucky lethal injection
protocol, which outlines the current standard for assessing whether or not
a method of execution is constitutional.4 ° In both Glossip and Baze, the
Court was unable to find that the petitioners had demonstrated a high
enough likelihood of a substantial risk of harm. 4 1 Both the Baze and
Glossip decisions noted that because the Court has previously upheld the
constitutionality of capital punishment, it follows that there should be a
means through which this can be carried out. 4 2 The Baze Court developed
the "substantial risk of harm" test to determine whether or not an
execution protocol is constitutional.4 3 The Court held that, where a
plaintiff could show that an imminent and substantial risk of future harm
in order for the scheme to be constitutional).
34.

See generally Baze v. Rees, 553 U.S. 35 (2008) (challenging Kentucky's three-drug

protocol under 42 U.S.C. § 1983, a civil rights statute).
35.

See 42 U.S.C. § 1983 (2015).

36. Id.
37.
38.
39.
40.

Id. § (I)(b)(33).
Id. § (I)(A).
Baze, 553 U.S. at 50.
See generally id. at 55 (holding that petitioners needed to establish a substantial risk of

harm in order for the court to find that a method of execution violates their Eighth Amendment
rights).
41.

See, e.g., Glossip v. Gross, 135 S. Ct. 2726, 2745-46 (2015) (declining to find any

Eighth Amendment violation where petitioners could not provide enough evidence that
midazolam could cause a substantial risk of future harm); Baze, 553 U.S. at 54 (proffering that
there was not an adequate showing that Kentucky's three drug protocol presented a substantial
risk of harm beyond possible future human error).
42. Baze, 553 U.S. at 48; Glossip, 135 S. Ct. at 2739.

43. See Baze, 553 U.S. at 49-50 (mandating that where a risk to future harm is sure or very
likely to cause illness and mental suffering and the dangers must be sufficiently imminent).
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existed, departments of correction officials violated his or her Eighth
Amendment rights. 44 The substantial risk of a method of execution must
be shown to be substantial compared to other viable and available
alternatives.45
In Baze, the plurality contended that petitioners only established that,
if not administered correctly, a lethal injection protocol would cause an
individual severe pain. 46 However, petitioners submitted that where the
lethal injection protocol in question was carried out correctly, there would
be no risk of pain. 47 The Court noted that because the risk of harm would
only occur as a result of human error, there was not a substantial risk that
the petitioners would suffer imminent harm. 48 The Court in Baze also held
that the
that simply providing a marginally safer alternative did not show
49
harm.
imminent
and
substantial
inflict
would
current protocol
In Glossip, the Court grappled with a lethal injection protocol
involving two drugs. The Court was still not able to find that the chemical
carried with it an inherent risk of harm. 50 Petitioners argued that because
midazolam had led to a prior botched execution, there was a substantial
risk of future harm to petitioners. 5 1 However, the Court pointed to various
rulings in lower courts that found the use of midazolam, when used in the
quantities required for lethal injection protocol to sedate an individual,
successfully sedated someone and declined to overrule these opinions.52
The Court again pointed to human error and found that this was the source
of the previously botched execution.53 Petitioners in Glossip also
challenged the requirement that a safer alternative needed to be provided
in a § 1983 lawsuit.54 The Court still held that petitioners were required
to provide a safer alternative. 55 The dissent noted that Baze did not require
a safer alternative but stated that the initial protocol did 56not carry with it
a substantial risk of harm as compared to an alternative.
Under the controlling jurisprudence of Baze, and to be successful in
any civil suit regarding an Eighth Amendment violation, a claimant must
44.

Id.

45.

Glossip, 135 S. Ct. at 2737. But see id at 2793-94 (Sotomayor, J., dissenting) (putting

forth the assertion that the majority incorrectly interpreted Baze in finding that a petitioner must
show a viable alternative method).
46.
47.
48.

Baze, 533 U.S. at 49.
Id.
Id. at 50.

49.

Id. at 52.

50.
51.
52.
53.
54.
55.

Glossip, 135 S. Ct. at 2746.
Id. at 2745.
Id. at 2739-40.
Id. at 2746.
Id. at 2738.
Id.

56. Id. at 2763-94 (Sotomayer, J., dissenting).
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prove that there is a possibility for varied errors and harm inherent in a
method of execution and establish a viable alternative to this method of
execution.

57

D. The Rationale Behind State DecisionsFindingMethods of
Execution Unconstitutional
Though the Supreme Court has yet to find a method of execution
unconstitutional, state courts have found electrocution unconstitutional
under state constitutions that prohibit cruel and unusual punishment.58 In
both Dawson v. State5 9 and Mata v. State,6° the courts reference state
constitutional prohibitions against cruel and unusual punishment, written
in language similar to the federal Eighth Amendment.6 '
In both of these decisions, the courts reference the federal Constitution
and Supreme Court jurisprudence. 62 Though these two states reviewed
the constitutionality of electrocution, other state courts have found that a
challenge to the constitutionality of electrocution where lethal injection
is the primary method through which a person will be executed is not ripe
63
for review.

57. See id. at 2739 (finding that the lack of a viable alternative method did not satisfy the
controlling jurisprudence of Baze); Baze v. Rees, 553 U.S. 35, 50 (2008) (mandating that a
claimant must show a safer alternative method of execution to succeed on the merits of a § 1983
claim). But cf Glossip, 135 S. Ct. at 2793-94 (Sotomayor, J., dissenting) (arguing that the Baze
court did not hold an alternative method was required, but simply held that a claimant could not
show a substantial risk of harm simply by showing a marginally safer alternative).
58. See, e.g., Dawson v. State, 554 S.E.2d 137, 143-44 (Ga. 2001) (using both the state and
federal constitutions to find that the risk of blistering bodies, cooking of the brain, and needless
injury that could be sustained when electrocution is used as an execution method constitutes cruel
and unusual punishment); State v. Mata, 745 N.W.2d 229, 278 (Neb. 2008) (mandating that with
the history of burned and charred bodies, electrocution cannot be a constitutionally viable means
of execution under the Nebraska constitution).
59. Dawson, 554 S.E.2d at 143-44.
60. Mata, 745 N.W.2d at 278.
61. Compare GA. CONST. art. I, § 1 XVII (asserting an individual's right to be free of
cruel and unusual punishment), andNEB. CONST. art I, § 9 (same), with U.S. CONST. amend. VII1
(same).
62. See Dawson, 554 S.E.2d at 329 (invoking evolving standards of decency as a reason to
find that electrocution was unconstitutional and would no longer be carried out in Georgia); Mata,
745 N.W.2d at 250 (proffering that the Eighth Amendment requires states-imposed capital
punishment procedures not in an arbitrary and capricious manner, as is required under Supreme
Court jurisprudence).
63. See, e.g., West v. Schofield, 460 S.W.3d 113, 131-32 (Tenn. 2015) (finding that where
Tennessee's statutory scheme indicated that an execution would only be carried out by
electrocution where lethal injection drugs were not available, a petitioner's challenge to the
constitutionality of execution by electrocution was not ripe because lethal injection drugs were
available).
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E. The Lobby of PharmaceuticalCompanies andPast Successes

Human rights groups and anti-death penalty lawyers have traditionally
used two different methods to prompt pharmaceutical companies to cease
the production of lethal injection chemicals: lawsuits and publicity
campaigns. 64 In lawsuits, pharmaceutical companies have been sued for
their involvement in botched executions. 65 Publicity campaigns involve
using the media and Internet platforms to highlight which pharmaceutical
companies are involved in the sale of drugs66 for execution and show why
their involvement is ethically problematic.
When states first began to administer lethal injection, they did so with
a three-drug protocol. 6 ' This three-drug sequence consisted of sodium
thiopental, 6 pancuronium bromide, 69 and potassium chloride, 7 ° released
in the order listed. 7 1 The first drug in this protocol that pharmaceutical
companies declined to procure was sodium thiopental, the drug used to
initially sedate an inmate.7 2 First, a company called Hospira could not
guarantee that they would not procure sodium thiopental produced in its

plant for use in lethal injection protocols, prompting the Italian
64. See, e.g., Htelping PharmaceuticalCompanies Stop Thair MAdicines Being Used to
Kill, REPRIEVE, http://www.reprieve.org.uk/case-study/issues-helping-pharmaceutical-companie
s-stop-their-medicines-being-used-to-kill/ (last visited Oct. 13, 2015) [hereinafter REPRIEVE]
(detailing the ways in which Reprieve, a human rights group, believes that contributing to the
supply of lethal injection drugs is bad for businesses and general human rights interests);
Associated Press, Family Sues in ProtractedOhio Execution, N.Y. TIMEs (Jan. 25, 2014), http://
www.nytimes.com/2014/01/26/us/family-sues-in-protracted-ohio-execution.html? r=0 (discussing a lawsuit against the pharmaceutical company, Hospira, for supplying drugs used in a botched
execution in Ohio).
65. See Associated Press, supra note 64.
66.
67.

See REPRIEVE, supra note 64.
See Baze v. Rees, 553 U.S. 35, 44 (2008) (stating that Kentucky uses a three-drug

protocol of sodium thiopental, pancorium bromide, and potassium chloride).
68. Sodium thiopental, commercially known as Pentothal, is a barbiturate used typically as
an anesthetic for "short surgical procedures with minimal painful stimuli," to control convulsions
and increased intracranial pressure, and to induce a hypnotic state. See Thiopental Sodium,
DRUGS.COM, http://www.drugs.com/ppa/thiopental-sodium.html (last visited Mar. 25, 2016).
69. Pancorium bromide, commercially known as Pavulon, is typically used in conjunction
with general anesthesia to relax muscles for the insertion of a tube into an individual's throat, and
is also used to provide both skeletal and muscle relaxation during surgery. See Pavulon, RxLIST,
http://www.rxlist.com/pavulon-drug/indications-dosage.htm (last visited Mar. 25, 2016).
70. Potassium chloride is a substance traditionally used to prevent or treat low levels of
potassium in the blood stream (known as hypokalemia). See Potassium Chloride,DRUGS.COM,
http://www.drugs.com/potassiumchloride.html (last visited Mar. 25, 2016).
71. Dustin Voltz, No Drugs,No Executions: The End oftheDeathPenalty, NAT'LJ. (2013),
http://www.nationaljoumal.com/innovation-works/no-drugs-no-executions-the-end-of-the-deat
h-penalty-20131028 (last visited July 25, 2015).
72. See Bonner, supra note 10 (detailing that up to 5000 milligrams of sodium thiopental
are released as execution protocol, while only 100 to 150 milligrams are released when sodium
thiopental is used as a surgical anesthetic).
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manufacturer to cease supply. 73 Human Rights groups in Europe then
74
began to put pressure on British manufacturers to cease their supply.
After the company, Dream Pharma, continued to procure sodium

thiopental for lethal injection, Reprieve, a European human rights group,
filed suit against the British government to halt the exportation of
thiopental for use in executions. 75 The British government eventually
agreed to stop the exportation.76

When sodium thiopental was no longer available, states began to use
pentobarbital as a sedative in a three-drug protocol, as the sole drug in a
lethal injection protocol, and as part of a three-drug protocol.7 7 The
primary European pharmaceutical company supplying pentobarbital
ceased supply in 2011. 78 Though pentobarbital has still been used in
executions through 2015, 7 9 there is no supply chain for many states, and
their stock of pentobarbital will expire or run out. 80 Some states have
turned toward compounding pharmacies in order to produce
pentobarbital. 8 1 Compounding human drugs are not approved by the
Food and Drug Administration (FDA). 82 States have also had to halt
73. Id.
74. See, e.g., id. (explaining that a human rights group, Reprieve, began to put pressure on
a British pharmaceutical company, Dream Pharma).
75. Id.
76. See id. (showing that although the British government initially responded to the lawsuit
by stating that there was no use in halting the export of thiopental because the U.S. government
would just get it elsewhere, the British effectively halted the exportation shortly after Reprieve's
request).
77. See Glossip v. Gross, 135 S. Ct. 2726, 2733-34 (2015) (noting that States eventually
replaced sodium thiopental with pentobarbital, another barbiturate intended to act as a sedative).
78. See, e.g., Rob Stein, New Obstacle to Death Penalty in US., WASH. POST (July 2,
2011), https://www.washingtonpost.com/national/health-science/20 1 1/07/02/AG5AgevH-story.
html (announcing that the sole procurer ofpentobarbital for lethal injection, Lundbeck, has traced
all of its supply and will no longer procure pentobarbital for lethal injection).
79.

See Executions List 2015, DEATH PENALTY INFO. CTR., http://www.deathpenaltyinfo.

org/execution-list-2015 (last visited Mar. 25, 2016) (showing that of the 28 individuals executed
in 2015, there were 18 executed with a one-drug protocol using just pentobarbital).
80. See, e.g., Austin Goode, Commonwealth Lethal Injection Drugto Expire in September:
States Seeking Alternative Suppliers, Methods, CAVALIER DAILY (Mar. 5, 2015, 9:47 PM),
http://www.cavalierdaily.com/article/2015/03/commonwealth-lethal-injection-drug-supply-to-ex
pire-in-september (expressing that Virginia's supply of both sodium thiopental and pentobarbital
is set to expire in September 2015, and as a result, the Virginia legislature passed a bill allowing
midazolam to be used only if sodium thiopental or pentobarbital are unable to be procured for
Virginia's lethal injection protocol).
81. Compounding pharmacies are pharmacies that do not face the same approval process
for their products that large manufacturers do, and can therefore combine, mix, or otherwise alter
chemicals for specific patients, or can make copies or near copies of commercially available drugs.
See Compounding Pharmacies and Lethal Injection, DEATH PENALTY INFO. CTR.,
http://www.deathpenaltyinfo.org/compounding-pharmacies (last visited Mar. 25, 2016).
82. See Compounding Quality Act: Title I of the Drug Quality and Security Act of 2013,
U.S. FOOD & DRUG ADMiN., http://www.fda.gov/drugs/GuidanceComplianceRegulatory
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executions entirely because of problems with compounded human
drugs. 83 The International Association for Compounding Pharmacists
(IACP) has
reprimanded the sale of compounded human drugs for
84
execution.

Many states have also turned toward the use of midazolam as the next
sedative to be used in either a two-drug protocol with potassium chloride,
or just a single one-drug protocol.85 Pharmaceutical companies have
already begun banning the use of their midazolam 86 in 87
executions and
executions.
in
midazolam
of
use
the
against
speaking out
Since the botched execution of Clayton Lockett in 2014, seven
executions have taken place with the use of midazolam as part of a twodrug and three-drug protocol. 88 The state set Richard Glossip's execution

on September 16, 2015 and an appeals court in Oklahoma stayed his
execution for two weeks for the gathering of evidence.8 9 In Virginia, the
Information/PharmacyCompounding/
(last visited Mar. 25, 2016) (reprimanding the
compounding of human drugs and mandating that no compounded drugs are approved by the
FDA).
83. See, e.g., Rhonda Cooke, Georgia OrdersMoratorium on Executions Amid Questions

About Lethal Injections, ATL. J. CONST. (Mar. 4, 2015) (explaining that the Georgia Supreme
Court ordered all executions to be postponed indefinitely after pentobarbital from a compounding
pharmacy appeared cloudy when examined before an execution, and the state planned to test all
of the drugs to ensure their efficacy).
84. See Press Release, IACP Adopts Position on Compounding of Lethal Injection Drugs
INT'L AcAD. OF COMPOUNDING PHARMACISTS (Mar. 24, 2015), http://www.deathpenaltyinfo.org/

documents/IACPPressRelease.pdf [hereinafter L4CP] (condemning the creation of lethal injection
drugs by compounding pharmacies and urging all member pharmacies to cease any involvement
in the production of lethal injection drugs).
85. See Glossip v. Gross, 135 S. Ct. 2726, 2734 (2015) (illustrating that where Oklahoma
was unable to procure any pentobarbital, the state moved toward midazolam as its first line drug).
See also Goode, supra note 80 (showing that where pentobarbital or sodium thiopental will not
be available, Virginia will use midazolam in their lethal injection protocol).
86. Midazolam is in a class of medications called benzodiazepines, and works on the
central nervous system to cause sleepiness, muscle relaxation, temporary memory loss, and a
reduction of anxiety. See Midazolam, DRUGS.COM, http://www.drugs.com/cdi/midazolam.html
(last visited Mar. 25, 2016).
87. See Tracy Connor, Drug Maker Akorn Bans Sedative Midazolamfor Executions, NBC
NEWS (Feb. 20, 2015, 8:34 AM), http://www.nbcnews.com/storyline/lethal-injection/drug-makerakorn-bans-sedative-midazolam-executions-n309191 (highlighting pharmaceutical company
Akorn's decision to cease the procurement of midazolam for use in lethal injection protocol);
Roche Statement, supra note 11 (indicating a major pharmaceutical company does not stand
behind the use of midazolam in lethal injection protocol).
88. See Executions List 2015, supra note 79 (listing two executions in Florida and
Oklahoma that took place in 2015 with midazolam as part of a three-drug protocol); Executions
List 2014, DEATH PENALTY INFO. CTR. CTR., http://www.deathpenaltyinfo.org/execution-list-

2014 (last visited Mar. 25, 2016) (showing that following the execution of Clayton Lockett on
Apr. 29, 2014, there were five executions in Florida, Arizona, and Texas, and Georgia).
89. Erik Eckholm, Richard Glossip Execution is Halted by Oklahoma Court, N.Y. TIMES
(Sept. 16, 2015), http://www.nytimes.com/2015/09/17/us/richard-glossip-execution-oklahoma.
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state set inmate Alfredo Prieto's execution date for October 1, 2015.9o As
a result of the drug shortages in Virginia, the Virginia Department of
Corrections had to request that the Texas Department of Corrections send
them pentobarbital made by an undisclosed pharmacy.91 A federal court
in Virginia stayed Alfredo Prieto's execution in order to determine the
constitutionality of using a drug from an undisclosed pharmacy before he
was executed on October 2nd.92
Many pharmaceutical companies have taken care to control the
production of chemicals that could be used in lethal injection procedures
and have either spoken out against the use of such chemicals in lethal
93
injection protocol or banned the use entirely.
F. Business Involvement in Past Civil Rights Litigation Successes
Civil rights litigation in the twenty-first century often engages
businesses in their attempts to curry public favor. 94 The goal of engaging
businesses is twofold: (1) to put increasing pressure on legislatures and
(2) to increase publicity surrounding the civil rights issue. Civil rights
html?r-0.
90. David G. Savage, CaliforniaKiller Faces Virginia Execution, L.A. TIMES (Sept. 17,
2015, 3:00 AM), http://www.latimes.com/nation/nationnow/la-na-califomia-killer-faces-virgini
a-execution-20150916-story.html.
91. Ian Simpson, Judge Orders Halt to Virginia Execution Pending Hearing on Drug,
REUTERS (Sept. 30, 2015, 5:23 PM), http://www.reuters.com/article/us-usa-execution-virginiaidUSKCNORU2SS20150930.
92. See id. (underlining that Prieto's lawyers believed, under controlling Baze
jurisprudence that Prieto could suffer imminent harm with the lack of information about the source
and efficacy of the pentobarbital from a compounding pharmacy). But see Associated Press,
Appeals Exhausted,Alfredo Prieto,Serial Killer,Is Executed, PRESS, N.Y. TIMES (Oct. 1, 2015),
http://www.nytimes.com/201 5/10/02/us/appeals-exhausted-alfredo-prieto-serial-killer-is-execute
d.html (demonstrating that a federal judge ruled that Prieto's lawyers did not show enough
evidence that the drug would be unsafe and it was in the public interest to continue with his
execution).
93. See, e.g., ParPharmaceuticalStatement on Brevital Sodium, PAR STERILE PRODUCTS
(May 28, 2014), http://www.parsterileproducts.com/news/releases/2014/brevital-sodium-stateme
nt.php (reprimanding the use of Brevital sodium, or methohexital sodium, a barbiturate used as a
sedative, in lethal injection protocol because it is not in line with Par Pharmaceutical's mission of
helping "improve the quality of life," and therefore vowing to preclude wholesalers from
accepting any orders from the department of correction); Scott Meacham, Fresenius Kabi
Statement (Aug. 28, 2012), http://deathpenaltyinfo.org/documents/FreseniusPropofolStatement.
pdf (announcing that the company, Fresenius Kabi, would not support the use of Propofol, an
anesthetic, for use in a lethal injection protocol and would ensure that no orders would be accepted
from any departments of correction in the United States).
94. See, e.g., Kenneth K. Hsu, Why the Politicsof MarriageMatter: EvaluatingLegal and
Strategic Approaches on Both Sides of the Debate on Same-Sex Marriages,20 BYU J. PUB. L.
275, 276 (2006) (referencing the same-sex marriage and the importance of engaging businesses
as part of a holistic strategy to legalize same-sex marriage).
95. Cf id. at 278 (linking business involvement and political pressure on legislatures to
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litigation campaigns permeate popular cultural and ethical considerations
for consumers, and thus, businesses have faced the potential loss of
profits and the inability to expand.96
In Obergefell v. Hodges,97 the Court ruled that state and federal
98
governments could no longer bar marriage rights for same-sex couples.
Immediately prior to this decision, businesses became important vehicles
through which human rights groups pressured legislatures and other
political entities. 99 For example, when the Indiana General Assembly
passed the 2015 Religious Freedom Law, the National College Athletes'
Association (NCAA) openly opposed the legislation and made a
statement showing its support for all athletes coming to Indianapolis
during a major basketball tournament. 100
The NCAA was not the only business the same-sex marriage debate
substantially affected. When a Georgia-based fast food chain, Chick-FilA, came out with a statement showing their support for traditional
marriage values and the organizations Chick-Fil-A supported that
crusade for traditional marriage values, a nationwide boycott of the fast
food chain ensued. 10 1 The statements even led public officials to call for
02
Legislatures actively banned the
boycotts of Chick-Fil-A in their areas. 1
chain from doing business in New York. As an openly gay councilman
stated, "They are not welcome here unless they can embrace all of New
continue to legalize same sex marriage).
96. See, e.g, Spatola, infra note 99 (examining the media response that a sports
organization orchestrated in the wake of the Indiana legislature passing a bill which allowed
businesses to celebrate their religious freedom by showing their lack of support for same-sex
marriage primarily through the ability to not serve individuals in the LGBT community); Ellis,
infra note 101 (highlighting that where a fast food chain spoke out against gay marriage and not
only faced individual boycotts, but also faced bans in parts of the country like New York City and
parts of Massachusetts, and therefore had to withdraw support from anti-LGBT groups even given
the fast food chain's staunch Christian values).
97. Obergefell v. Hodges, 135 S.Ct. 2584 (2015).
98. See id. at 2598 (holding that because the right to marry is fundamental under the Due
Process clause of the U.S. Constitution, the Court cannot find that same-sex couples should not
be denied their due process rights by not allowing same-sex couples to marry).
99. See, e.g., Chris Spatola, Indiana's 'Religious Freedom Law' is the Real March
Madness, THE HILL (Mar 31, 2015), http://thehill.com/blogs/pundits-blog/civil-rights/237426indianas-religious-freedom-law-is-the-real-march-madness (highlighting the negative response
from the National College Athletes' Association (NCAA) in response to the passage of Indiana's
religious freedom act, which allowed business discrimination based on sexuality).
100. Id.
101. See Phillip Ellis, Is Your Business Gay-Friendly? More and More Companies Are
Banking On It, HUFF. POST (Nov. 7, 2012), http://www.huffingtonpost.com/philip-ellis/gayfriendly-business b 2041126.html (explaining that when Chick Fil A made a statement opposing
same-sex marriage after information about the fast food chain donating to causes that opposed
marriage equality, many people began to boycott the restaurant).
102. See, e.g., id. (highlighting that the mayor of Boston and the Alderman of Chicago both
called for boycotts of Chick-Fil-A in their respective areas).
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York's diverse community, including the LGBT community. " "'
lmmediately following these statements, which were made in early 2012,
Chick-Fil-A announced that it had pulled funding from organizations
pushing traditional marriage values and LGBT discrimination.' 04 Itwas
only after Chick-Fil-A took the care to clarify its position on same-sex
marriage and LGBT rights that they could expand in New York City.' 05
The situation with both Chick-Fil-A and the NCAA indicates that civil
rights campaigns, indeed, have a very clear effect on businesses.'0 6
HI. THE REASONS FOR THE SUCCESS OF THE PHARMACEUTICAL
LOBBY AND THE GENERAL EFFECTIVENESS OF BUSINESS
INVOLVEMENT IN CIVIL RIGHTS LITIGATION

Pharmaceutical companies have begun responding to developments in
lethal injection protocols at a quicker pace. 1 7 As a result of this quick
pace and the shortage of lethal injection chemicals around the United
States, many states are resorting to methods that medical and
pharmaceutical professionals have found problematic (like compounding
pharmacies), 10 8 and some states have ceased executions entirely because
of problems with these methods. 109 Pharmaceutical companies often cite
their mission statements and ethical duties as reasons for which they
refuse to participate in the execution of other human beings. " 0 A large
103. Alexander C. Kaufman, Chick-Fil-A Hopes NYC Will Forgetthat Whole Hating-Gays
Thing, HUFF. POST (Apr. 9, 2014), http://www.huffingtonpost.com/2014/04/09/chick-fil-a-newyork-city_n_5120387.html.
104. See Ellis, supra note 101.
105. See Kaufman, supra note 103 (reporting that Chick-Fil-A will be opening a location in
New York City following the boycott that would not allow the opening of New York City
locations for the fast food chain).
106. See, e.g., id.(indicating that in order to grow their business, Chick-Fil-A had to adjust
their policies in order to expand into areas in the Northeast).
107. Compare Bonner, supra note 10 (showing that pharmaceutical companies did not
object to the use of sodium thiopental until 2011 and after increasing pressure from human rights
organizations), and State-by-State Lethal Injection, supra note 3 (stating that sodium thiopental
was first used in Texas in 1982), with Meacham, supra note 93 (preempting the use of propofol
in lethal injection protocol before legislation allowed its use or before it was used in a lethal
injection protocol).
108. See, e.g., IACP, supra note 84 (confirming that the IACP does not support the
compounding of human drugs for use in lethal injection, which states like Georgia and Florida
have used, and discourages all member pharmacies from participating in the creation of lethal
injection drugs).
109. See, e.g., Cooke, supra note 83 (establishing that a Georgia court imposed a
moratorium on all executions until lethal injection drugs were tested to ensure their efficacy after
they appeared cloudy prior to an execution).
110. See, e.g., FreseniusKabi Statement, supranote 93 (highlighting that because Fresenius
Kabi's mission statement is to improve lives, it does not want its products to be associated with
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majority of pharmaceutical companies also have strong ties to European
producers, and lethal injection medications have largely come from
European companies, where capital punishment is largely seen as

inhumane."' As such, pharmaceutical companies indicate that their
mission statement and business ties will continue to make any
involvement in the sale1 12
of chemicals for the purpose of state-sanctioned
execution problematic.'
In contrast, § 1983 litigation has twice failed in the Supreme Court
113
and has not made headway in federal district and appellate courts.
Courts in the United States are bound to uphold the Constitution.
14
However, no court has yet found lethal injection to be unconstitutional.
It is, therefore, more likely that the ethical and reputational concerns of
pharmaceutical companies will continue prompting the halt on the
procurement of lethal injection drugs than it is that courts will find that
lethal injection in the current state is unconstitutional entirely. 11 5 Thus, in
the litigation strategy to end the death penalty, pharmaceutical companies
are integral to creating an environment where capital punishment is
unbearably difficult to implement and plagued by delays, thereby
increasing the potential that general Eighth Amendment jurisprudence
regarding evolving standards of decency will dictate a court ruling (1)
that capital punishment in its current state is unconstitutional, (2) that
capital punishment in its current state is administered counter to the
Eighth Amendment, 116
or (3) that capital punishment places too large a
burden on the courts.
ending the lives of inmates); Roche Statement, supra note 11 (affirming that Roche, a
pharmaceutical company, supports a worldwide ban on the death penalty and does not support the
use of any of its products for the purpose of state-sanctioned execution).
111. Cf Bonner, supra note 10 (referring to the European companies who banned the
procurement of chemicals for use in lethal injection cocktails, and to U.S. companies whose
European plants declined to continue producing certain lethal injection chemicals).
112. See, e.g., Conner, infra note 129 (citing the concern that an investment firm had in
investing in a pharmaceutical company that procures lethal injection drugs because of the ethical
problems investors will see).
113. See Glossip v. Gross, 135 S. Ct. 2726, 2746 (2015) (holding that there was not a
sufficient showing of a substantial risk of future harm through the use of midazolam in lethal
injection protocol); Baze v. Rees, 553 U.S. 35, 63 (2008) (sustaining a lower court ruling that
Kentucky's three drug protocol did not present a serious risk of substantial harm).
114. See, e.g., Glossip, 135 S. Ct. at 2746 (holding that petitioners did not show enough
evidence that midazolam would cause them imminent harm); Baze, 553 U.S. at 63 (mandating
that petitioners could not show a substantial risk of harm simply by arguing that there is a
marginally safer alternative).
115. Compare Conner, infra note 129 (showing that ethical and business concerns have
caused pharmaceutical companies strife like significant hits to their funding which make them
unable to produce lethal injection chemicals), with Glossip, 135 S. Ct. at 2733-34 (stating that
because the Court has held that capital punishment is constitutional, there must be a constitutional
means of carrying it out).
116. See Furman v. Georgia, 408 U.S. 238, 242 (1976) (Douglas, J., concurring) (referring
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A. How PharmaceuticalCompanies Are Able to Prevent the Use of New
Drugs with Existing Statutory Vagueness
Statutory language does not specify the type of chemicals that
departments of correction should use in an execution. 117 Thus,
pharmaceutical companies are in a position where more commonly
known chemicals may be used in lethal injection protocols. For example,
it is possible under state statutes to use Valium, a common anti-anxiety
medication in the same medication family as midazolam, as a sedative
agent.1 1 As pharmaceutical companies look to maintain their public
image and ensure they are not supplying chemicals used in lethal
injection protocols, they will likely begin supplying more basic chemicals
with the stipulation that they not be used in state-sanctioned
executions. 119 State-sanctioned executions have also increasingly
involved more commonly known chemicals that register to the average
person more than would general anesthetic agents. 120 For example,
midazolam is in a class of chemicals called benzodiazepines, which
include popular and common anti-anxiety medications such as Xanax,
Valium and Klonopin, all
of which are frequently prescribed for the
21
management of anxiety. 1
Statutory vagueness has not proven innately problematic in the
response of pharmaceutical companies to potential new lethal injection
protocols. Pharmaceutical companies Fresenius Kabi and Par
Pharmaceuticals were able to respond to suggestions to use certain drugs

to the need to reference society's evolving standards of decency to determine what could violate
the Eighth Amendment); State v. Mata, 745 N.W.2d 229, 278 (Neb. 2008) (indicating that where

a method of execution poses too great a risk of future harm, a state will abandon this method
entirely); Jones v. Chappell, 31 F. Supp. 3d 1050, 1051 (C.D. Cal. 2014) (estopping future

injections in California because of the unnecessary delays involved in carrying out executions and
the arbitrariness with which individuals are executed in California).
117.

See Ky. REV. STAT. ANN. § 431.200 (West 2015) (requiring only that under statute, a

department of corrections must run a lethal amount of a substance through a prisoner's veins until
dead).

118. See Midazolam, supra note 86 (identifying that Midazolam is a benzodiazepine, a class
of chemicals that also includes Valium).
119.

See, e.g., Roche Statement, supra note 11 (stating that pharmaceutical companies

should began to only procure midazolam with a stipulation that it will not be used for lethal
injection).
120.

Cf Execution List 2014, supra note 88 (displaying an execution in Oklahoma which

took place using midazolam and hydromorphone, a common painkiller used in many hospitals
throughout the United States).
121. See Midazolam, supra note 86 (pointing out that midazolam is in the class of
medications known as benzodiazepines); Benzodiazepine Drug Information, RxLIST: THE

INTERNET DRUG INDEX, http://www.rxlist.com/benzodiazepines/drugs-condition.htm (last visited
Sept. 17, 2015) (identifying that benzodiazepines are chemicals used for treating anxiety and
panic, and that Xanax, Valium, and Klonopin are all in this class of drugs).
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in a lethal injection protocol by banning their supply for that purpose
122
before there was a demand from the Department of Corrections.
Additionally, pharmaceutical companies' quick reaction to the
implementation of midazolam as part of states' lethal injection protocols
indicates that
following the unavailability of pentobarbital
pharmaceutical companies are more aware of the potential for certain
classes of chemicals to be used in a lethal injection protocol. 123 These two
developments lessen the burden that statutory vagueness would otherwise
impose on pharmaceutical companies in halting the procurement of
potential lethal injection chemicals.
B. The Business Implications of Involvement in Capital
Punishmentand the Business Interests that PromptPharmaceutical
Companies to Cease Procurementof Lethal InjectionDrugs
European companies made the decision to cease procurement of drugs
within a year of the commencement of lobbying efforts. 124 This indicates
huge success on the part of human rights organizations and anti-death
penalty lawyers. However, lobbying by these organizations was just one
part of a broader decision to cease procurement of these chemicals. The
decision of European companies to completely cease the sale of lethal
injection drugs was largely based on the desire to avoid the potential
business implications for companies and investment firms linked to
companies involved in lethal injections.' 2 5 On its website, a human rights
group called Reprieve examines the numerous reasons why a
pharmaceutical company would choose to withdraw their supply of lethal
injection chemicals.F2 6 Among the reasons listed are (1) the damage that
botched executions can do to business reputations and (2) the possibility
127
of being involved in lawsuits surrounding botched lethal injections.
Reprieve also examines the ways in which a pharmaceutical company
could take a significant financial hit, such as when investors view a
122. See Meacham, supra note 93 (requiring that no propofol be sold to the department of
corrections to ensure that it could not be potentially used in executions); Par Pharmaceutical
Statement, supra note 93 (directing that no Brevital sodium be sold to the department of

corrections to estop the use of this chemical in lethal injection protocol).
123.

Cf Roche Statement, supra note 11 (discrediting the use of midazolam in lethal

injection protocols in 2014).
124. See Bonner, supra note 10 (showing that companies in Denmark and the United
Kingdom ceased production of sodium thiopental in late 2013 after a human rights group began
pressuring the companies and their governments).
125. See, e.g., Conner, infra note 129 (noting the business concerns that an investment firm
had with their investors discovering any potential investment in a pharmaceutical company
involved in lethal injection).
126. See REPRIEVE, supra note 64.
127. Id.
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company involved in capital punishment increasingly warily. 128
Reprieve is correct in noting that businesses face increased hits to their
investments if they continue to supply lethal injection drugs. 129 Financial
firms and major investors have stated that it is a huge public relations
problem for their names to be linked to lethal injection, and in order to
avoid this public relations problem, they have pulled their financial
support from companies supplying lethal injection drugs. 130 These public
relations problems and ethical concerns also cause problems for
companies themselves. When Danish and British companies declined to
continue to procure lethal injection chemicals to Departments of
Corrections, they did so largely to avoid the public relations problems
they were encountering from Reprieve's publicity campaigns and the
resulting news coverage. 131
In 2013, when Reprieve effectively lobbied pharmaceutical
companies to cease the sale of sodium thiopental, the negative publicity
focused primarily on how investors and consumers in the European
Union would negatively perceive these companies. 132 However, ethical
positions of pharmaceutical companies in the United States also prompt
a refusal to supply drugs for lethal injection, and U.S.-based companies
have been subject to investment hits and lawsuits. 133 These developments
indicate that American pharmaceutical companies will be subject to
further negative publicity and will invoke ethical and human rights
norms. 134 Additionally, American companies face hits to their
investments when they choose to continue to sell lethal injection

128. Id.
129. See, e.g., Tracy Conner, Drug Maker Mylan Takes $70 Million Hit in Battle Over
Lethal Injection, NBC NEWS (Oct. 21, 2014), http://www.nbcnews.com/storyline/lethal-

injection/drug-maker-mylan-takes-70-million-hit-battle-over-lethal-n230051
(noting that a
German financial firm pulled $70 million dollars from a Pennsylvania-based pharmaceutical
company that supplied drugs to Texas' department of corrections for lethal injection).
130. See id. (demonstrating that where a German financial firm pulled support from a drug
company supplying lethal injection drugs, the possibility that clients may find out they had shares

in a company that was involved in lethal injection was too great a risk).
131.

See, e.g., Bonner, supra note 10 (showing that under pressure from Reprieve and

campaigns against the British government, a British company and Danish company both ceased
the sale of sodium thiopental to departments of corrections).
132.

Cf id (noting that Reprieve invoked European standards of human rights to laud

European pharmaceutical companies for their involvement in the procurement of lethal injection
drugs).
133. See Assoc. Press, supra note 64 (examining a lawsuit launched against Hospira for their
involvement in a botched Ohio execution); Roche Statement, supra note 11 (invoking the mission
statement of an American pharmacy in promoting improving individual's lives, rather than
contributing to an individual's death).
134. See, e.g., Roche Statement, supra note 11 (listing ethical norms of an American-based
company in their decision to cease the sale of midazolam to departments of corrections).
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chemicals to Departments of Corrections.' 35 These increased risks to
business provide increasing incentives for pharmaceutical companies to
cease the procurement of lethal injection drugs to ensure that their
investments do not fall 36and that their business is perceived favorably in
order to keep sales up.'
C. The "Chick-Fil-A Effect": Are PharmaceuticalCompanies
Susceptible to Similar PublicRelations andFinancialProblems Due to
Involvement in the Procurementof Lethal Injection Drugs?
The pressure put on Chick-Fil-A during the same-sex marriage debate
demonstrates the ways in which a business must be cognizant of public
perception in order to keep its profits and business reputation high.' 37 In
the case of Chick-Fil-A, many of the individuals who boycotted the
chain-and many of the legislatures that spoke out against the fast food
chain-supported LGBT rights, including same-sex marriage, and
generally identified as liberal. 13 8 Additionally, the boycott was so
damaging to Chick-Fil-A that the company was forced to adopt different
views, even though the company's CEO and COO are both Christians,
and the company itself has extremely close ties to the Christian Church. 13 9
It is worth noting that even a company with such strong ties to the
Christian community and Christian ideals still felt it was necessary to
keep their support for traditional marriage values quiet, and instead
support an inclusive0 employment policy lauding the inclusion of the
LGBT community.14

It is also worth noting that the religious ties Chick-Fil-A cited for their
initial inability to support same-sex marriage are religious ties that
pharmaceutical companies do not have. However, these religious ties
135.

See Assoc. Press, supra note 64 (noting the ease with which foreign investors can pull

financial support for pharmaceutical companies involving themselves in the sale of lethal injection
drugs).
136. Cf Ellis, supra note 101 (pointing out that where a company faced hit to profits and an
inability to expand in certain areas of the United States prompted a withdrawal of their
involvement in LGBT discrimination).
137. Cf id. (illustrating that where Chick-Fil-A's profits and ability to expand in the
Northeast and other areas with primarily liberal voters, the company decided to withdraw its
comments about LGBT rights and circulate internally instructions on creating an inclusive
working and restaurant environment).
138. Ellis, supra note 101.
139. See id. (demonstrating that Chick-Fil-A has close ties to the Christian, specifically
Baptist church).

140. See id. (putting forth the notion that after the potential financial hit that Chick-Fil-A
could take as a result of the boycott, it took less than a year for the Christian company to denounce
discrimination against LGBT officials); Bonner, supra note 10 (highlighting that human rights
concerns as well as the concern for negative publicity were primary reasons for European
companies to cease the sale of lethal injection chemicals to departments of correction).
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somewhat mirror the ethical considerations and pressures pharmaceutical
companies are under from investors. 14 1 For this reason, the campaigns
targeting European companies which were previously involved in the
procurement of lethal injection drugs mirror the campaigns surrounding
the gay marriage debate because both companies find themselves subject
to the pressures of consumers and investors. 142 In the case of European
pharmaceutical companies, human rights organizations like Reprieve
publicly appealed to British and Danish companies and worked with
governments to try to halt the sale of lethal injection drugs. 143 In the
campaign against Chick-Fil-A for its open disdain for same-sex marriage
and its support of organizations that actively worked against the LGBT
community, lobbying organizations ensured that there was publicity
surrounding these decisions, and government officials became involved
when they actively asserted their resolve to support boycotts of the fast
food chain within their areas. 144
Chick-Fil-A's profits were never reported to have fallen significantly,
illustrating the possibility that Chick-Fil-A chose to tone down its
statements about LGBT rights and cease their funding of conservative
groups supporting LGBT discrimination purely to ensure that their
business reputation thrived and that they could expand into areas with
45
more liberal constituents. 1
Pharmaceutical companies are aware of the negative publicity that
comes with the sale of lethal injection drugs. 146 It is entirely possible that
the same pressure Chick-Fil-A felt to pull their support from groups that
engaged in LGBT discrimination will be felt by pharmaceutical groups
to ensure that their businesses do not take the same hit to investments as
47
Chick-Fil-A's did. 1

141. See Conner, supra note 129 (crediting the ethical concerns of clients as a key part of
the decision to cease investment in pharmaceutical companies that are involved in lethal
injection).
142. Compare id. (indicating that in order to ensure an investment firm flourishes
financially, they cannot take the risk of involving themselves in business deals with
pharmaceutical companies that procure drugs for lethal injection), with Ellis, supra note 101

(arguing that where the possibility for business expansion was limited, Chick-Fil-A had to change
their policies toward same-sex marriage to curry popular favor).
143.

Cf Bonner, supra note 10 (detailing the ways in which Reprieve reached out to the

British government, and attempted to appeal to the human rights obligations of companies under
European Union human rights obligations).
144. See Ellis, supra note 101 (cataloging the number of politicians calling for regional
boycotts of Chick-Fil-A, and the personal boycotts many individuals took).
145. Cf id. (highlighting the ways in which Chick-Fil-A opted to promote inclusion to
ensure they could expand and avoid the continuation of prior negative publicity).
146. See, e.g., Roche Statement: Statement on the Use of Midazolam for the Death Penalty,
supra note 11 (noting that the company publicly stated they wish to promote life improvement

and not the death of human beings).
147. Cf Ellis, supra note 101 (examining the business interest which lines up with major
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D. The Effect that PharmaceuticalCompanies Have Had on Court and
Legislative Decisions
The "substantial risk of harm" test, as set forth in Baze, dictates that a
complainant must demonstrate that the risk of harm he or she could
suffer, as a result of an execution method, is imminent and cannot be
demonstrated
simply through a demonstrated risk resulting from human
148
error.
In both Baze and Glossip, the petitioners challenged methods of
execution that had already been used successfully, and the respondents
successfully argued that the only harm both petitioners could show would
result-or did result-from human error. 149 First, as the various
Departments of Corrections attempt to execute prisoners with chemicals
that are not well known to courts and the medical community in terms of
their effectiveness as lethal injection chemicals, the potential
for courts
150
to be unduly burdened by civil rights litigation is high.
Second, as pharmaceutical companies decline to procure known
methods of execution and Departments of Corrections move toward more
unorthodox chemicals, a complainant could challenge this new method,
and under the controlling jurisprudence, there would be little evidence of
the success of a new drug. Therefore, a court could potentially find that
without evidence of any success with a chemical in a lethal injection
for
protocol, and without a medical consensus that the chemical is 5safe
1
lethal injection, there is a substantial risk of harm to a prisoner.1
Third, as the method of lethal injection has become more difficult to
implement, states have passed legislation permitting more arcane
methods of execution to be used where lethal injection chemicals cannot
be procured. 152 As the potential for prisoners to be executed using these
methods becomes more imminent, it is likely that a court could decide to
civil rights pushes).
148. See Baze v. Rees, 553 U.S. 35, 50 (2008) (clarifying that while an isolated mishap is

regrettable, it does not indicate cruelty or the potential for substantial risk of harm).
149.

See, e.g., Glossip v. Gross, 135 S. Ct. 2726, 2746 (2015) (declining to find that

Oklahoma's execution protocol indicated a substantial risk of harm primarily because the majority
found that human error was responsible for the botched execution that petitioners used to indicate
the potential for a substantial risk of harm); Baze, 553 U.S. at 51 (claiming that petitioners could
not succeed on the merits of their substantial risk of harm claim because the only indication they
presented of harm was to show a slightly more safe alternative).
150. Cf Glossip, 135 S. Ct. at 2734-35 (maintaining that the petitioner could not show a
substantial risk of harm primarily because Oklahoma put in safeguards to fix human error with
one botched execution, because there was evidence it would work in other executions).
151. Cf Baze, 553 U.S. at 50 (indicating that where there is more than simply a risk of
human error, the harm a prisoner could suffer would be considered imminent).
152.

See Methods of Execution, supra note 2 (demonstrating that some states have a backup

method of execution where lethal injection is not available, which include firing squad in Utah
and lethal gas in Oklahoma).
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assess whether or not these methods of execution are still
constitutional. 53
'
Finally, as states turn toward more arcane or unorthodox methods of
execution, it is likely that Eighth Amendment jurisprudence could cause
a court to assess the constitutionality of the death penalty in its current
state altogether. 154 It is more likely that as a court reviews these methods
under broader Eighth Amendment jurisprudence concerning evolving
standards of decency, a court could find that evolving standards of
decency do not support capital punishment where only more arcane
methods or unorthodox chemicals can be used because of the refusal of
pharmaceutical companies to involve themselves in the procurement of
lethal injection drugs. 155 Evolving standards of decency require that
courts assess whether or not there is an Eighth Amendment violation
under changing societal standards, and as the pharmaceutical lobby
prompts the move toward more unorthodox and less understood methods
of execution, capital punishment
will not hold up under Eighth
156
Amendment jurisprudence.

E. How the Use of CompoundingPharmaciesHave Affected the Courts
The lawsuit filed on behalf of Alfredo Prieto in federal court in
Virginia is one of the recent challenges to the use of compounding
pharmacies in the development of lethal injection drugs. 157 Though in
Prieto's most recent case, the court upheld the secrecy of the
compounding pharmacy producing lethal injection drugs in Texas, they
only did so because they did not believe Prieto's lawyers presented
enough evidence to demonstrate the imminent harm he could potentially
158
suffer.
153.

See, e.g., Dawson v. State, 554 S.E.2d 137, 139 (Ga. 2001) (indicating a willingness to

review the constitutionality of electrocution where it was possible a prisoner would be executed
using electrocution).
154. See generally Roper v. Simmons, 543 U.S. 551, 555 (2005) (referencing Supreme
Court jurisprudence which states the Eighth Amendment should be interpreted under the

"evolving standards of decency that mark the progress of a maturing society.") (citing Trop v.
Dulles, 356 U.S. 86, 101 (1958)).
155. Cf Furman v. Georgia, 408 U.S. 238, 242 (1976) (Douglas, J., concurring) (referring
to jurisprudence establishing that society's evolving standards of decency should dictate whether

or not there is an Eighth Amendment violation).
156.

See Trop v. Dulles, 356 U.S. 86, 101 (1958) (decrying that the Eighth Amendment

must continue to draw its meaning from the "evolving standards of decency that mark the progress
of a maturing society.").
157. Cf Simpson, supra note 91 (highlighting that a court was willing to consider whether
or not the refusal of a department of corrections to reveal information about drugs they receive
from compounding pharmacies or the names of the pharmacies themselves).
158.

See id. (showing that the judge dismissed the claim only because he could not find

enough evidence in the pleading before him, but not because he believed the imminent harm could
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Compounding pharmacies arguably do not face the same pressures as
do larger pharmaceutical companies with business reputations and public
images at stake. 159 However, much like how the pharmaceutical industry
has generally come out against the supply of chemicals for lethal
injection, the governing body for compounding pharmacies has also come
out against the involvement of compounding pharmacies in the
development of drugs for human execution. 160 As compounding
pharmacies become a more popular vehicle through which Departments
of Corrections can procure lethal injection drugs, the publicity
mirror the publicity surrounding
surrounding their involvement could
16 1
larger pharmaceutical companies.

Compounding pharmacies also create the potential for varied lawsuits
that will ultimately burden the courts. 162 As compounding pharmacies
and their drugs are used more and more, lawyers for capitally charged
inmates have the ability to challenge the constitutionality of compounded
lethal injection cocktails, particularly where information about the chain
of custody of these drugs is not readily available to the inmate. 163 As
courts continue to review these claims, it is increasingly more likely that
a court could find that the use of compounding pharmacies violates
Eighth Amendment jurisprudence under Baze because where the source
of these drugs is unknown, their efficacy is also unknown. 164 Courts are
also vulnerable to suit under the recent Beaty v. FDA ruling. 165 Under the
holding in Beaty, a claimant could argue that because compounding
pharmacies are kept out of the public eye, it is possible that they have
not be demonstrated).
159. See id. (demonstrating that where compounding pharmacies' anonymity is maintained,
they do not face external pressure or the possibility of public relations problems).
160. See IACP, supra note 84 (reprimanding the participation of compounding pharmacies
in the production of lethal injection drugs).
161. Cf Bonner, supra note 10 (demonstrating that where knowledge of pharmaceutical
companies' involvement in lethal injection became known, campaigns to stop their involvement
put these companies directly in the public eye and caused their eventual decision to pull the sale
of drugs for lethal injection).
162. See, e.g., Simpson, supra note 91 (showing that a lawsuit was filed in federal court
challenging the constitutionality of using compounding pharmacies); Cooke, supra note 83
(highlighting that after a Georgia appeals court examined the state of cloudy lethal injection
medication made from a compounding pharmacy, the court ruled that there could be no more
executions until the chemicals were thoroughly tested).
163. Cf Simpson, supra note 91 (crediting the lack of knowledge regarding the drug's
source and efficacy with the reasons for filing suit in federal court to request an injunction for an
execution).
164. Cf id. (claiming that Prieto's lawyers argued that it was unconstitutional that there was
no knowledge of the chain of supply for the drugs the Texas Department of Corrections supplied
for Prieto's execution).
165. See Beaty v. FDA, 853 F. Supp. 2d 30, 32 (2012) (decrying that all foreign sourced
drugs must be turned over for inspection before use within the United States).
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foreign drugs that would need to be turned over to the FDA for
inspection. 6
Compounding pharmacies appear to be an unfortunate side effect of
the lack of available drugs from pharmaceutical companies. However,
lawsuits and execution delays indicate that courts will only continue to
encounter problems with compounding pharmacies. 167 All of these tactics
could be used to delay executions, place undue burden on the courts, and
place burdens on various Departments of Corrections.

IV. How ANTI-DEATH

PENALTY ADVOCATES SHOULD CONTINUE TO
ENGAGE PHARMACEUTICAL COMPANIES TO BOLSTER THE
LIKELIHOOD OF AN END TO THE DEATH PENALTY

In order for anti-death penalty advocates to be successful in their
efforts, they must continue to examine possible lethal injection protocols
that could develop as other drugs are made unavailable for lethal
injection. For example, where Florida sought to replace its three-drug
protocol with midazolam, anti-death penalty advocates must develop a
strategy to anticipate which of these drugs will be used in place of
protocols that become unavailable. Luckily, more and more of these
drugs are passed through legislation or are contested in lawsuits and are,
therefore, brought into the public eye. When these drugs are in the public
eye, pharmaceutical companies have also kept a close watch on
developments in legislation without the urging of human rights groups
and anti-death penalty lawyers, and they have been able to declare their
unwillingness to sell new drugs to the various Departments of Corrections
for use in executions.
Where the state seeks to use drugs that are more readily available to
the public-for example, when the state attempts to use high doses of
Valium as a sedative in an injection protocol-pharmaceutical companies
producing these drugs should be encouraged to sell potential lethal
injection substances with a stipulation that these chemicals are not used
for state-sanctioned executions in order to avoid negative publicity.
Halting the sale of these more common drugs to a Department of
Corrections entirely is not feasible because the drugs are used to treat
certain psychiatric conditions, and inmates should have the ability to still
treat these conditions. Thus, pharmaceutical companies will not
experience a hit to their overall revenue or sales as the amount the
Department of Corrections would use specifically for lethal injections
166. Id.
167.

See, e.g., Simpson, supra note 91 (indicating that courts are beginning to consider the

problems with the secrecy surrounding compound pharmacies); Cooke, supra note 83 (showing
that because of issues with compounding human drugs, Georgia had to halt executions until 2015).
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would be relatively small compared to the amount that pharmaceutical
companies make off of a drug.
Additionally, anti-death penalty lawyers should continue to file
lawsuits challenging the constitutionality of the more unorthodox
methods of execution as drugs become less available to states as a result
of the pharmaceutical lobby. Though analysis has shown that the
pharmaceutical lobby has been more effective up to this point, the clear
way to ensure that capital punishment is ruled unconstitutional, because
of potential Eighth Amendment violations or because of its burden on the
courts, must eventually be decided in a court of law. As courts continue
to review the constitutionality of the death penalty as it stands, they must
face enumerated changes in lethal injection protocol and execution
protocol in general as more traditional methods of execution become
unavailable. As pharmaceutical companies decline to procure drugs
needed for lethal injections, this will provide an environment in which a
court could more easily find that the death penalty is no longer
constitutional or effective in the United States and, therefore, end the
practice altogether.
Where courts have been able to find that a method of execution
demonstrates a risk of harm and does not come with an assurance that the
individual will not suffer extreme pain, courts have been able to rule
methods of execution unconstitutional. Therefore, as lethal injection
protocols change with the increasing lack of available lethal injection
drugs, it will be that much easier for a court to find that the procedure
does not meet society's evolving standards of decency.
Additionally, as the process becomes more plagued by delays and
problems with execution methods, anti-death penalty advocates should
focus on politicians, as the abandonment of lethal injection in many states
has come at the request of governors or legislatures that see increased
delays and inhumane practices occurring. As the courts continue to be
burdened by extensive capital punishment litigation-both through civil
litigation and through writs of habeas corpus-and as lethal injection
becomes more difficult to carry out, it is increasingly likely that other
states will abandon capital punishment at the request of their legislatures
or political officials.

V. CONCLUSION

Pharmaceutical companies are almost certainly not the type of allies
that human rights activists and anti-death penalty lawyers anticipated.
However, this Note has proven that these companies may prove to be
their most important allies when it comes to using more unorthodox
methods to attack the death penalty. While it is possible that public
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opinion alone could drive the judicial landscape to a place where the
Supreme Court could find that under evolving standards of decency,
capital punishment is no longer sufficient under Eighth Amendment
prohibitions on cruel and unusual punishment, the willingness of
pharmaceutical companies to procure the drugs necessary for lethal
injections plays a huge role in establishing whether or not protocols can
be considered safe and painless. This Note has already shown that
pharmaceutical companies have both business and ethical interests in
ensuring that they do not actively procure drugs for lethal injection
protocol.
Public perception of state action is integral to many major civil rights
decisions. In the United States, individuals often use the phrase "vote
with my dollar." Companies are under increasing pressure to appeal to
public perception, and as the inefficiency of lethal injection becomes
clearer, the public perception of whether or not the practice should
continue has shifted toward a belief that it should not. This growing
public knowledge of the problems with lethal injection combined with
pharmaceutical companies' business interests in removing their products
from potential use in a lethal injection cocktail will create a much
different environment for lethal injection. It will be an environment
where a court could likely review the practice of lethal injection in a
particular state, or in the United States as a whole, and find that it is either
unconstitutional or no longer efficient, thereby ending the practice of
capital punishment in America permanently.
ADDENDUM

On May 13, 2016, Pfizer announced that it would cease the sale of
lethal injection drugs to all departments of correction. 168 Pfizer was the
last free market pharmaceutical company to sell lethal injection drugs. 169
Pfizer restricted the sale of drugs that some states have now turned toward
lethal injections: pancuronium bromide, potassium chloride, propofol,
midazolam, hydromorphone, rocuronium bromide, and vecuronium
bromide.17 ° As a result, all states will have to rely on compounding
pharmacies and
other untested drugs to carry out lethal injections from
17 1
here on out.

168. See National Public Radio, Pfizer to Stop Selling Drugsfor Use in Lethal Injections,
NPR (May 13, 2016, 8:21 AM), http://www.npr.org/sections/thetwo-way/2016/05/13/47800008
4
/pharmaceutical-company-pfizer-t-stop-selling-drugs-for-use-in-lethal-injections.
169. Id.
170. Id.
171. Id.

